Zhao Yuwu

[Expert Profile] Zhao Yuwu, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in neurodegenerative diseases in China, working in the Department of Neurology, Shanghai Sixth People's Hospital. He has long been dedicated to the clinical and basic research of prion diseases, fatal familial insomnia, neurodegenerative diseases, and other rare difficult disorders, and is a renowned scholar in the field of neurodegenerative and difficult neurology in China.

[Education & Career] Professor Zhao Yuwu graduated from a renowned medical university, has been deeply involved in the field of neurology for decades, and further studied at famous international medical research institutions, systematically mastering cutting-edge research methods in neurodegenerative disease and neuropathology. He has long served at Shanghai Sixth People's Hospital, holding academic positions in the Neurology Physicians Branch of the Chinese Medical Doctor Association, and has presided over projects including the National Natural Science Foundation of China and major Shanghai municipal research programs, achieving a series of results in the clinical and translational research of neurodegenerative diseases.

[Areas of Expertise] Professor Zhao specializes in the diagnosis and differential diagnosis of rare neurodegenerative diseases such as prion diseases and fatal familial insomnia (FFI), as well as the standardized diagnosis and treatment of common neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and motor neuron disease. He has extensive experience in cerebrospinal fluid biomarker testing, genetic testing interpretation, and imaging interpretation. He excels at identifying rare diseases among complex cognitive impairment, sleep disorders, and extrapyramidal symptoms, identifying the causes of long-misdiagnosed difficult degenerative disease patients, and providing symptomatic and supportive treatment.

[Academic Achievements & Industry Contributions] Professor Zhao has conducted domestically leading systematic research in the fields of prion diseases and fatal familial insomnia, leading the establishment of clinical diagnosis and follow-up systems for related diseases, with research findings published multiple times in authoritative domestic and international journals, providing important data for the epidemiological and clinical research of rare neurodegenerative diseases in China. He has actively participated in the development of China's rare disease catalog and diagnostic standards, promoted the application of new technologies such as genetic testing and biomarkers in early diagnosis of neurodegenerative diseases, and conducted research on whole-course management and care for neurodegenerative diseases, making important contributions to improving the diagnosis, treatment, and care standards for neurodegenerative diseases in China.

[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Zhao has treated tens of thousands of neurodegenerative disease patients and various difficult neurological cases. He is exceptionally patient with every rare disease patient, insisting on detailed inquiry of family history and medical history details, and has successfully identified the truth behind rare cases where "the whole family could not find the cause" on multiple occasions. He has been invited to deliver special reports at national academic conferences on multiple occasions, and actively popularized standardized neurodegenerative diagnosis and treatment knowledge to grassroots physicians. He is an expert in the field of neurodegenerative diseases trusted by patients and recognized by peers, and his dedication and academic demeanor are widely praised.

[Honors & Reputation] Professor Zhao Yuwu has long held relevant positions in the Neurology Branch of the Shanghai Medical Association, and has presided over grants from the National Natural Science Foundation of China and major Shanghai municipal research programs. He is a senior expert in the fields of neurodegenerative diseases and rare diseases in China. He has accumulated extensive experience in the diagnosis and treatment of rare difficult diseases such as prion diseases, fatal familial insomnia, and neurodegenerative diseases. He has led the establishment of a rare neurodegenerative disease clinical and pathological diagnosis collaboration platform, promoted the standardized clinical application of genetic testing and cerebrospinal fluid testing technologies, and participated in the development of multiple Chinese diagnostic standards for neurological rare diseases, with research findings receiving provincial and ministerial science and technology awards. With noble medical ethics and rigorous scholarship, he has helped numerous rare disease patients receive clear diagnoses and standardized management, and is deeply trusted by patients.